Pettinga Financial Advisors, LLC Eli Lilly & CO Transaction History

Pettinga Financial Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$724.87 - $909.04 $56,539 - $70,905	78 Added 17.85%	515 $466,000
Q1 2024 Apr 17, 2024	BUY	$592.2 - $792.28 $258,791 - $346,226	437 New	437 $339,000
Q2 2023 Jul 17, 2023	BUY	$350.74 - $468.98 $1.45 Million - $1.94 Million	4,141 New	4,141 $1.94 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Pettinga Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Pettinga Financial Advisors, LLC with notifications on news.